BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 25327562)

  • 1. Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-κB signaling pathway.
    Zhang N; Chu ES; Zhang J; Li X; Liang Q; Chen J; Chen M; Teoh N; Farrell G; Sung JJ; Yu J
    Oncotarget; 2014 Sep; 5(18):8330-40. PubMed ID: 25327562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro.
    Wang J; Zhao J; Chu ES; Mok MT; Go MY; Man K; Heuchel R; Lan HY; Chang Z; Sung JJ; Yu J
    J Pathol; 2013 Aug; 230(4):441-52. PubMed ID: 23625826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knocking out peroxisome proliferator-activated receptor (PPAR) alpha inhibits radiation-induced apoptosis in the mouse kidney through activation of NF-kappaB and increased expression of IAPs.
    Zhao W; Iskandar S; Kooshki M; Sharpe JG; Payne V; Robbins ME
    Radiat Res; 2007 May; 167(5):581-91. PubMed ID: 17474796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E
    Chang-Lee SN; Hsu HH; Shibu MA; Ho TJ; Tsai CH; Chen MC; Tu CC; Viswanadha VP; Kuo WW; Huang CY
    Pathol Oncol Res; 2017 Jul; 23(3):477-485. PubMed ID: 27757837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour necrosis factor alpha down-regulates the expression of peroxisome proliferator activated receptor alpha (PPARα) in human hepatocarcinoma HepG2 cells by activation of NF-κB pathway.
    Lim WS; Ng DL; Kor SB; Wong HK; Tengku-Muhammad TS; Choo QC; Chew CH
    Cytokine; 2013 Jan; 61(1):266-74. PubMed ID: 23141142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of HSP27 on NF-kappaB pathway activation may be involved in metastatic hepatocellular carcinoma cells apoptosis.
    Guo K; Kang NX; Li Y; Sun L; Gan L; Cui FJ; Gao MD; Liu KY
    BMC Cancer; 2009 Mar; 9():100. PubMed ID: 19331697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
    Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
    Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.
    Sun L; Beggs K; Borude P; Edwards G; Bhushan B; Walesky C; Roy N; Manley MW; Gunewardena S; O'Neil M; Li H; Apte U
    Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G91-G104. PubMed ID: 27151938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription.
    Wu MH; Ma WL; Hsu CL; Chen YL; Ou JH; Ryan CK; Hung YC; Yeh S; Chang C
    Sci Transl Med; 2010 May; 2(32):32ra35. PubMed ID: 20484730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro.
    Yu J; Shen B; Chu ES; Teoh N; Cheung KF; Wu CW; Wang S; Lam CN; Feng H; Zhao J; Cheng AS; To KF; Chan HL; Sung JJ
    Hepatology; 2010 Jun; 51(6):2008-19. PubMed ID: 20512989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation.
    Mo SJ; Hou X; Hao XY; Cai JP; Liu X; Chen W; Chen D; Yin XY
    Cancer Commun (Lond); 2018 Apr; 38(1):9. PubMed ID: 29764501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase-3 suppresses diethylnitrosamine-induced hepatocyte death, compensatory proliferation and hepatocarcinogenesis through inhibiting p38 activation.
    Shang N; Bank T; Ding X; Breslin P; Li J; Shi B; Qiu W
    Cell Death Dis; 2018 May; 9(5):558. PubMed ID: 29752472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homeostatic regulatory role of Pokemon in NF-κB signaling: stimulating both p65 and IκBα expression in human hepatocellular carcinoma cells.
    Zhang NN; Sun QS; Chen Z; Liu F; Jiang YY
    Mol Cell Biochem; 2013 Jan; 372(1-2):57-64. PubMed ID: 23054188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COMMD7 is correlated with a novel NF-κB positive feedback loop in hepatocellular carcinoma.
    Zheng L; Deng CL; Wang L; Huang XB; You N; Tang YC; Wu K; Liang P; Mi N; Li J
    Oncotarget; 2016 May; 7(22):32774-84. PubMed ID: 27129158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma.
    Chen S; Zheng P; Wang W; Yi M; Chen P; Cai J; Li J; Peng Q; Ban Y; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Xiang B
    J Cell Physiol; 2018 Jun; 233(6):5002-5013. PubMed ID: 29227538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor α positively regulates complement C3 expression but inhibits tumor necrosis factor α-mediated activation of C3 gene in mammalian hepatic-derived cells.
    Mogilenko DA; Kudriavtsev IV; Shavva VS; Dizhe EB; Vilenskaya EG; Efremov AM; Perevozchikov AP; Orlov SV
    J Biol Chem; 2013 Jan; 288(3):1726-38. PubMed ID: 23168409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3.
    Zhao N; Wang R; Zhou L; Zhu Y; Gong J; Zhuang SM
    Mol Cancer; 2014 Feb; 13():35. PubMed ID: 24565101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
    Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
    J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenofibrate induced PPAR alpha expression was attenuated by oestrogen receptor alpha overexpression in Hep3B cells.
    Jeng LB; Velmurugan BK; Hsu HH; Wen SY; Shen CY; Lin CH; Lin YM; Chen RJ; Kuo WW; Huang CY
    Environ Toxicol; 2018 Feb; 33(2):234-247. PubMed ID: 29134746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice.
    Lin H; Yan J; Wang Z; Hua F; Yu J; Sun W; Li K; Liu H; Yang H; Lv Q; Xue J; Hu ZW
    Hepatology; 2013 Jan; 57(1):171-82. PubMed ID: 22859216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.